617 related articles for article (PubMed ID: 19195555)
1. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
Cho WJ; Jena BP; Jeremic AM
Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes.
Cho WJ; Trikha S; Jeremic AM
J Mol Biol; 2009 Oct; 393(3):765-75. PubMed ID: 19720065
[TBL] [Abstract][Full Text] [Related]
3. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
[TBL] [Abstract][Full Text] [Related]
4. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
[TBL] [Abstract][Full Text] [Related]
5. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
Nilsson MR; Raleigh DP
J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
[TBL] [Abstract][Full Text] [Related]
6. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells.
Konarkowska B; Aitken JF; Kistler J; Zhang S; Cooper GJ
FEBS J; 2006 Aug; 273(15):3614-24. PubMed ID: 16884500
[TBL] [Abstract][Full Text] [Related]
7. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
[TBL] [Abstract][Full Text] [Related]
8. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
Lorenzo A; Razzaboni B; Weir GC; Yankner BA
Nature; 1994 Apr; 368(6473):756-60. PubMed ID: 8152488
[TBL] [Abstract][Full Text] [Related]
10. Watching amyloid fibrils grow by time-lapse atomic force microscopy.
Goldsbury C; Kistler J; Aebi U; Arvinte T; Cooper GJ
J Mol Biol; 1999 Jan; 285(1):33-9. PubMed ID: 9878384
[TBL] [Abstract][Full Text] [Related]
11. Interaction of hIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of hIAPP oligomers.
Weise K; Radovan D; Gohlke A; Opitz N; Winter R
Chembiochem; 2010 Jun; 11(9):1280-90. PubMed ID: 20440729
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
[TBL] [Abstract][Full Text] [Related]
13. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
14. Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.
Khemtémourian L; Lahoz Casarramona G; Suylen DP; Hackeng TM; Meeldijk JD; de Kruijff B; Höppener JW; Killian JA
Biochemistry; 2009 Nov; 48(46):10918-25. PubMed ID: 19817482
[TBL] [Abstract][Full Text] [Related]
15. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
Nagarajan S; Ramalingam K; Neelakanta Reddy P; Cereghetti DM; Padma Malar EJ; Rajadas J
FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
[TBL] [Abstract][Full Text] [Related]
16. Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions.
Zhao J; Yu X; Liang G; Zheng J
Biomacromolecules; 2011 Jan; 12(1):210-20. PubMed ID: 21158384
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and diabetes: inhibition of amylin aggregation by nonsteroidal anti-inflammatory drugs.
Thomas T; Nadackal GT; Thomas K
Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):8-11. PubMed ID: 12605343
[TBL] [Abstract][Full Text] [Related]
18. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
[TBL] [Abstract][Full Text] [Related]
19. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
